Here are five things to know:
1. The report looks at vaccines, pharmaceuticals and technologies for deliveries of therapeutics.
2. Nanotechnology in virology is featured, as well as systemic delivery of antiviral agents and vaccines.
3. The report provides a SWOT analysis of antiviral approaches.
4. Profiles of 188 companies that develop technologies are included.
5. Pharmaceutical, biopharmaceutical, antiviral drug and viral vaccine companies are analyzed.
More articles on quality & infection control:
The ASC infection control manifesto: 4 essentials for survey readiness
Extension Healthcare awarded for alarm safety software: 5 points
NIH study to combat RSV infection — 5 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.